🛡️ Public data only — no PHI permitted on this instance.

HOSP

MARY IMOGENE BASSETT HOSPITAL

CCN 330136|LOC COOPERSTOWN, NY|BEDS 160|NPR $529.1M|MARGIN -31.6%

SeekingChartis Score

INVESTMENT THESIS

Buy: MARY IMOGENE BASSETT HOSPITAL

/ 100 (B)

+$38.9M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$529.1M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

59%

CATALYSTS

▲RCM uplift of $38.9M (+736bps)

RISKS

▼Elevated distress risk (41%)

Buy — solid fundamentals with identifiable value creation levers. Proceed to detailed diligence.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$529.1M

Net Patient Revenue

-31.6%

Operating Margin

$-167.1M

Net Income

160

Licensed Beds

$3,307K

Revenue per Bed

$696.2M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · 36%■ MEDICAID · 2%■ COMMERCIAL · 61%

Score Breakdown

SCComposite · 26/100

Component	Score	Max	%
Market Position	18	35	53%
Financial Health	0	25	0%
Operational Quality	0	20	0%
Competitive Moat	2	20	11%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
330004	THE KINGSTON HOSPITAL	147	$0M
330005	KALEIDA HEALTH	954	$0M
330006	ST. JOSEPHS MEDICAL CENTER	106	$0M
330008	WYOMING COUNTY COMMUNITY HOSPITAL	47	$0M
330009	BRONXCARE HEALTH SYSTEM	454	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN NYStart Diligence · creates a deal from HCRIS